E

Edesa Biotech
D

EDSA

2.18000
USD
0.13
(6.34%)
Market Closed
Volume
0
EPS
-2
Div Yield
-
P/E
-0
Market Cap
7,079,308
OverviewSignalsIdeasNews
Related Instruments
    B
    BE
    7.850
    (59.07%)
    21.140 USD
    B
    BLDP
    0.01500
    (1.18%)
    1.28500 USD
    P
    PLUG
    -0.10500
    (-5.33%)
    1.86500 USD
    More
News

Title: Edesa Biotech

Sector: Healthcare
Industry: Biotechnology
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.